Maternal and infant outcomes in pregnant patients with MS treated with natalizumabApril 26, 2022Multiple Sclerosis
Progression independent of relapse activity is a major cause of CDA in early relapsing MSApril 26, 2022Multiple Sclerosis
Multiple sclerosis: B-cell depleting therapies hinder nAb response following SARS-CoV-2 vaccinationApril 26, 2022Multiple Sclerosis
Relapsing MS: Ofatumumab demonstrates superior benefit-risk profile than teriflunomide in RDTN patientsApril 26, 2022Multiple Sclerosis
Adverse childhood experiences associated with increased multiple sclerosis risk in womenApril 26, 2022Multiple Sclerosis
PMS: pNfL could serve as biomarker for disability progression and drug responseApril 26, 2022Multiple Sclerosis
MS: Fingolimod cessation safe if followed by prompt commencement of new therapyApril 26, 2022Multiple Sclerosis
RMS: Extended ofatumumab treatment presents favorable benefit-risk profile in ALITHIOS studyMarch 21, 2022Multiple Sclerosis
Multiple sclerosis: Discontinuing fingolimod improves humoral response after SARS-CoV-2 vaccinationMarch 21, 2022Multiple Sclerosis
Flu vaccination does not increase risk for infections or relapse in MSMarch 21, 2022Multiple Sclerosis
Masitinib at 4.5 mg/kg/day shows promise in progressive forms of multiple sclerosis March 21, 2022Multiple Sclerosis
